Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human rabies vaccine (Vero cell) Phase IV lot consistency and safety study
CTR20191083Phase 4Completed
- Sponsor
- Dalian Yalifeng Biopharmaceutical
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Purified Vero cell rabies vaccine in rabies, sponsored by Dalian Yalifeng Biopharmaceutical. Started May 2019; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20191083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191083.